Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Hereditary Cancer in Clinical Practice
Published in: Hereditary Cancer in Clinical Practice 1/2013

Open Access 01-12-2013 | Research

Receptivity and preferences of pancreatic cancer family members for participating in lifestyle programs to reduce cancer risk

Authors: Lisa A Howell, Pamela S Sinicrope, Tabetha A Brockman, Christi A Patten, Paul A Decker, Shawna L Ehlers, Ashley Nadeau, Kari G Rabe, Carmen Radecki Breitkopf, Gloria M Petersen

Published in: Hereditary Cancer in Clinical Practice | Issue 1/2013

Login to get access

Abstract

Background

Cancer is a shared family experience that might provide an opportunity for lifestyle change among at-risk family members. The purpose of this study was to assess receptivity and preferences for cancer risk reduction programs among at-risk family members with two or more relatives affected with pancreas cancer.

Methods

We surveyed 401 at-risk family members in an existing pancreatic cancer family registry. Participants completed a mailed survey which examined demographic, medical, and psychosocial correlates of willingness to participate in lifestyle cancer risk reduction programs. Multivariable generalized estimating equation approaches were used to model preferences.

Results

Overall, 85% (n = 342) of at-risk family members were receptive to lifestyle cancer risk reduction programs. Participant preferred programs focused on nutrition (36%, n = 116) and weight management (33%, n = 108), with Web/Internet (46%, n = 157) being the most preferred delivery channel. Most respondents preferred to participate in programs with their family or friends (74%, n = 182), rather than alone (25%, n = 85). In multivariable analysis, younger age (p = 0.008) and higher perceived likelihood of developing cancer (p = 0.03) were associated with willingness to participate in lifestyle programs.

Conclusions

Family members of those with pancreatic cancer are receptive to cancer risk reduction programs focusing on nutrition and weight management delivered via the internet. Further research is indicated to determine how to best incorporate a family-based approach when designing lifestyle intervention programs.
Literature
1.
Petrin K, Bowen DJ, Alfano CM, Bennett R: Adjusting to pancreatic cancer: perspectives from first-degree relatives. Palliat Support Care 2009,7(3):281–288. 10.1017/S1478951509990204CrossRefPubMed
2.
3.
Baum A, Andersen BL: Psychosocial interventions for cancer. Washington, DC, US: American Psychological Association; 2001.CrossRef
4.
Lerman C, Daly M, Sands C, Balshem A, Lustbader E, Heggan T, Goldstein L, James J, Engstrom P: Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst 1993,85(13):1074–1080. 10.1093/jnci/85.13.1074CrossRefPubMed
5.
Hart AR, Kennedy H, Harvey I: Pancreatic cancer: a review of the evidence on causation. Clin Gastroenterol Hepatol 2008,6(3):275–282. 10.1016/j.cgh.2007.12.041CrossRefPubMed
6.
Steinberg WM, Barkin JS, Bradley EL 3rd, DiMagno E, Layer P, Canto MI, Levy MJ: Should patients with a strong family history of pancreatic cancer be screened on a periodic basis for cancer of the pancreas? Pancreas 2009,38(5):e137-e150. 10.1097/MPA.0b013e3181a86b2cCrossRefPubMed
7.
Anderson LN, Cotterchio M, Gallinger S: Lifestyle, dietary, and medical history factors associated with pancreatic cancer risk in Ontario Canada. Cancer Causes Control 2009,20(6):825–834. 10.1007/s10552-009-9303-5CrossRefPubMedPubMedCentral
8.
Giovannucci E, Michaud D: The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 2007,132(6):2208–2225. 10.1053/j.gastro.2007.03.050CrossRefPubMed
9.
Larsson SC, Orsini N, Wolk A: Body mass index and pancreatic cancer risk: a meta-analysis of prospective studies. Int J Cancer 2007,120(9):1993–1998. 10.1002/ijc.22535CrossRefPubMed
10.
Luo J, Iwasaki M, Inoue M, Sasazuki S, Otani T, Ye W, Tsugane S: Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study in Japan–the JPHC study. Cancer Causes Control 2007,18(6):603–612. 10.1007/s10552-007-9002-zCrossRefPubMed
11.
Kristeller JL, Hebert J, Edmiston K, Liepman M, Wertheimer M, Ward A, Luippold R: Attitudes toward risk factor behavior of relatives of cancer patients. Prev Med 1996,25(2):162–169. 10.1006/pmed.1996.0042CrossRefPubMed
12.
Lemon SC, Zapka JG, Clemow L: Health behavior change among women with recent familial diagnosis of breast cancer. Prev Med 2004,39(2):253–262. 10.1016/j.ypmed.2004.03.039CrossRefPubMed
13.
Carlos RC, Dempsey AF, Patel DA, Dalton VK: Cervical cancer prevention through human papillomavirus vaccination: using the "teachable moment" for educational interventions. Obstet Gynecol 2010,115(4):834–838. 10.1097/AOG.0b013e3181d502d7CrossRefPubMedPubMedCentral
14.
McBride CM, Ostroff JS: Teachable moments for promoting smoking cessation: the context of cancer care and survivorship. Cancer Control 2003,10(4):325–333.PubMed
15.
Sutherland G, White V: Teachable moments in diet and nutrition for family and friends calling the Cancer Helpline. Aust N Z J Public Health 2005,29(4):388–389. 10.1111/j.1467-842X.2005.tb00213.xCrossRefPubMed
16.
Baider L, Surbone A: Cancer and the family: the silent words of truth. J Clin Oncol 2010,28(7):1269–1272. 10.1200/JCO.2009.25.1223CrossRefPubMed
17.
Garces YI, Patten CA, Sinicrope PS, Decker PA, Offord KP, Brown PD, Clark MM, Rummans TA, Foote RL, Hurt RD: Willingness of cancer patients to help family members to quit smoking. Psychooncology 2011,20(7):724–729. 10.1002/pon.1768CrossRefPubMed
18.
McWilliams RR, Bamlet WR, Cunningham JM, Goode EL, de Andrade M, Boardman LA, Petersen GM: Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. Cancer Res 2008,68(12):4928–4935. 10.1158/0008-5472.CAN-07-5539CrossRefPubMedPubMedCentral
19.
Faschingbauer T, Zisook S, DeVaul R: The Texas revised inventory of grief. In Biopsychosocial Aspects of Breavement. Edited by: Zisook S. Washington, DC: American Psychiatric Press; 1987:111–124.
20.
Jerusalem M, Schwarzer R: Self-efficacy as a resource factor in stress appraisal process. In Self-efficacy: Thought control of action. Edited by: Schwarzer R. Washington, D.C: Hemisphere; 1992:195–213.
21.
Schwarzer R, Renner B: Health Specific Self-Efficacy Scales. Berlin: Germany; 1996.
22.
Marcus BH, Selby VC, Niaura RS, Rossi JS: Self-efficacy and the stages of exercise behavior change. Res Q Exerc Sport 1992,63(1):60–66. 10.1080/02701367.1992.10607557CrossRefPubMed
23.
Godin G, Shephard RJ: A simple method to assess exercise behavior in the community. Can J Appl Sport Sci 1985,10(3):141–146.PubMed
24.
25.
Hay JL, Buckley TR, Ostroff JS: The role of cancer worry in cancer screening: a theoretical and empirical review of the literature. Psychooncology 2005,14(7):517–534. 10.1002/pon.864CrossRefPubMed
26.
Bishop MM, Beaumont JL, Hahn EA, Cella D, Andrykowski MA, Brady MJ, Horowitz MM, Sobocinski KA, Rizzo JD, Wingard JR: Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls. J Clin Oncol 2007,25(11):1403–1411. 10.1200/JCO.2006.07.5705CrossRefPubMed
27.
Hawkins NA, McCarty F, Peipens LA, Rodriquez JL: Measuring the degree of closeness to the cancer experience: development and initial validation of the CONNection to the Experience of Cancer Scale (CONNECS). Patient Educ Counseling 2012,89(2):292–299. 10.1016/j.pec.2012.08.009CrossRef
28.
Gulanick M, Bliley A, Perino B, Keough V: Recovery patterns and lifestyle changes after coronary angioplasty: the patient's perspective. Heart Lung 1998,27(4):253–262. 10.1016/S0147-9563(98)90037-1CrossRefPubMed
29.
Speechly C, Bridges-Webb C, McKenzie S, Zurynski Y, Lucas A: Patient and general practitioner attitudes to healthy lifestyle behaviours and medication following coronary heart disease: an exploratory study. Aus J Primary Health 2010,16(2):154–158. 10.1071/PY09011CrossRef
Metadata
Title
Receptivity and preferences of pancreatic cancer family members for participating in lifestyle programs to reduce cancer risk
Authors
Lisa A Howell
Pamela S Sinicrope
Tabetha A Brockman
Christi A Patten
Paul A Decker
Shawna L Ehlers
Ashley Nadeau
Kari G Rabe
Carmen Radecki Breitkopf
Gloria M Petersen
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Hereditary Cancer in Clinical Practice / Issue 1/2013
Electronic ISSN: 1897-4287
DOI
https://doi.org/10.1186/1897-4287-11-3

Other articles of this Issue 1/2013

Hereditary Cancer in Clinical Practice 1/2013 Go to the issue

Case report

Should extragonadal germ cell tumors be included in studies of families with testicular germ cell tumors?

Research

Experience of BRCA1/2 mutation-negative young women from families with hereditary breast and ovarian cancer: a qualitative study

Review

Hereditary breast cancer: ever more pieces to the polygenic puzzle

Research

Psoriasis vulgaris and familial cancer risk- a population-based study

Review

Hereditary cancer risk assessment: essential tools for a better approach

Research

Optimizing recruitment to a prostate cancer surveillance program among male BRCA1 mutation carriers: invitation by mail or by telephone
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits